1. Home
  2. UMH vs ETON Comparison

UMH vs ETON Comparison

Compare UMH & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UMH Properties Inc.

UMH

UMH Properties Inc.

N/A

Current Price

$14.78

Market Cap

1.3B

Sector

Real Estate

ML Signal

N/A

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

N/A

Current Price

$69.23

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UMH
ETON
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
UMH
ETON
Price
$14.78
$69.23
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$18.50
★ $80.75
AVG Volume (30 Days)
★ 618.9K
474.8K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 6.04%
N/A
EPS Growth
★ 133.33
N/A
EPS
0.06
★ 1.48
Revenue
★ $261,754,000.00
$79,950,000.00
Revenue This Year
$8.84
$125.03
Revenue Next Year
$7.82
$59.47
P/E Ratio
$248.33
★ $46.01
Revenue Growth
8.81
★ 104.94
52 Week Low
$13.93
$14.27
52 Week High
$16.77
$68.38

Technical Indicators

Market Signals
Indicator
UMH
ETON
Relative Strength Index (RSI) 42.80 73.95
Support Level $14.75 $48.58
Resistance Level $15.84 N/A
Average True Range (ATR) 0.34 3.53
MACD -0.03 2.19
Stochastic Oscillator 31.85 99.82

Price Performance

Historical Comparison
UMH
ETON

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: